SCHEMBL1083786

SCHEMBL1083786

Cc1cc(Nc2nc(-c3nccc4ccccc34)nc3ccccc23)[nH]n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.46
GSK3A P49840 4/20 0.46
AURKA O14965 4/20 0.46
SRC P12931 2/20 0.46
AURKB Q96GD4 2/20 0.46
EIF2AK2 P19525 1/20 0.46
TGFBR1 P36897 5/20 0.45
ADORA3 P0DMS8 1/20 0.42
PRKD1 Q15139 1/20 0.40
MAPK14 Q16539 1/20 0.40
MAPT P10636 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ABCB1 P08183 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27592459 0.83 GSK3B (0.48) GSK3BGSK3AAURKASRCAURKB
SCHEMBL802114 0.82 AURKA (0.69) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786402 0.82 GSK3B (0.65) GSK3BGSK3AAURKASRCAURKB
SCHEMBL801821 0.81 GSK3B (0.69) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786265 0.81 GSK3B (0.68) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786318 0.80 GSK3B (0.62) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786285 0.80 AURKA (0.69) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786854 0.79 CYP1A2 (0.60) GSK3BGSK3AAURKASRCAURKB
SCHEMBL786683 0.79 GSK3B (0.49) GSK3BGSK3AAURKASRCAURKB
SCHEMBL785492 0.78 GSK3B (0.54) GSK3BGSK3AAURKASRCAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed